I disagree on that timeline.
Quote...
ASX ANNOUNCEMENT28 November 2022FDA approves Early Feasibility Study for the DurAVR™ THV System
"It is anticipated the study will commence in early 2023."
End quote.
early does not equal mid year or second half of the year.
Ann: Latest Patient Group Show Best Results to Date at 30 Days, page-56
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.98 |
Change
-0.020(0.17%) |
Mkt cap ! $247.7M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.20 | $11.50 | $128.0K | 10.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 206 | $11.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.12 | 150 | 1 |
View Market Depth
| Last trade - 14.41pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |